APA (7th ed.) Citation

K, P., G, Y., Y, T., N, T., P, G., L, C., . . . S, P. (2013). Defective mismatch repair and benefit from bevacizumab for colon cancer: Findings from NSABP C-08. Journal of the National Cancer Institute, 105(13), 989. https://doi.org/10.1093/jnci/djt140

Chicago Style (17th ed.) Citation

K, Pogue-Geile, et al. "Defective Mismatch Repair and Benefit from Bevacizumab for Colon Cancer: Findings from NSABP C-08." Journal of the National Cancer Institute 105, no. 13 (2013): 989. https://doi.org/10.1093/jnci/djt140.

MLA (9th ed.) Citation

K, Pogue-Geile, et al. "Defective Mismatch Repair and Benefit from Bevacizumab for Colon Cancer: Findings from NSABP C-08." Journal of the National Cancer Institute, vol. 105, no. 13, 2013, p. 989, https://doi.org/10.1093/jnci/djt140.